Alerce Investment Management, L.P. - Q3 2021 holdings

$146 Million is the total value of Alerce Investment Management, L.P.'s 7 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 28.6% .

 Value Shares↓ Weighting
AMWL  AMERICAN WELL CORPcl a$57,400,000
-27.6%
6,300,7730.0%39.29%
-8.7%
ANNX  ANNEXON INC$36,382,000
-17.3%
1,954,9780.0%24.90%
+4.2%
ALRN  AILERON THERAPEUTICS INC$16,942,000
-18.4%
16,609,4490.0%11.60%
+2.9%
AKBA  AKEBIA THERAPEUTICS INC$13,399,000
-24.0%
4,652,5610.0%9.17%
-4.2%
NewAADI BIOSCIENCES INC$11,007,000374,785
+100.0%
7.53%
ASMB  ASSEMBLY BIOSCIENCES INC$7,752,000
-10.3%
2,227,5000.0%5.31%
+13.1%
GBT  GLOBAL BLOOD THERAPEUTICS IN$3,217,000
-27.3%
126,2700.0%2.20%
-8.2%
ARPO ExitAERPIO PHARMACEUTICALS INC$0-5,621,835
-100.0%
-5.16%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AMERICAN WELL CORP12Q3 202362.9%
ANNEXON INC12Q3 202335.9%
AKEBIA THERAPEUTICS INC12Q3 202331.6%
ASSEMBLY BIOSCIENCES INC12Q3 20238.7%
AADI BIOSCIENCES INC9Q3 202324.1%
AILERON THERAPEUTICS INC8Q3 202214.4%
GLOBAL BLOOD THERAPEUTICS IN8Q3 202223.4%
AILERON THERAPEUTICS INC4Q3 20232.3%
AERPIO PHARMACEUTICALS INC3Q2 20215.2%

View Alerce Investment Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-13
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-04
13F-HR2022-05-13
13F-HR2022-02-09
13F-HR2021-11-15

View Alerce Investment Management, L.P.'s complete filings history.

Compare quarters

Export Alerce Investment Management, L.P.'s holdings